Babcock & Wilcox more than doubled six-month revenue. It did not double the operating profit that came with it.
Revenue rose 130.3% to $319.7 million in the six months ended June 30, 2026, from $138.9 million a year earlier. Operating income increased 67.7% to $11.8 million, which means operating margin narrowed from 5.1% to 3.7%.
That is the filing's central tension: the business got much larger, but each dollar of sales produced less operating income. Management attributes the pressure to a heavier mix of large projects, which carry higher costs to complete.
The company put that explanation plainly in its latest 10-Q:
"The increase is primarily driven by the higher revenue as described above as well as the product mix of higher large project volume which carries higher costs needed to complete certain projects."
Babcock & Wilcox, Form 10-Q, August 10, 2026
The six-month revenue surge therefore came with a project mix involving higher costs, at least for reported operating margin. Operating income still rose by $4.8 million, but not at the pace of sales.
Net income moved from a $58.5 million loss to $14.3 million of profit, alongside a $64.4 million non-cash change in the fair value of customer warrants. The company says that mark was driven by fluctuations in its own stock price, which had increased relative to December 31, 2025. The mark is an accounting adjustment, not cash received from customers.
The cash line improved, too, but only to roughly break-even: operating cash flow moved from negative $33.8 million to positive $374,000. Cash on hand reached $308.6 million, while accounts receivable rose 76.3% to $170.7 million. The company does not disclose in these facts what drove the cash-balance increase.
Capital spending also rose, up 94.3% to $13.7 million. Babcock & Wilcox said the investing outflow was primarily tied to fixed-asset purchases for BrightLoop projects:
"Cash flows used in investing activities was $9.9 million in the six months ended June 30, 2026, primarily due to purchases of fixed assets relating to BrightLoop ™ projects, partially offset by proceeds from the sale of businesses and other asset disposals of $3.9 million."
Babcock & Wilcox, Form 10-Q, August 10, 2026
The balance sheet also carries a second scaling question. Diluted shares rose 56.5% year over year to 154.5 million, while stock compensation climbed to $14.8 million. Management linked the compensation increase to the rise in the company's share price and higher valuations for stock appreciation rights. The higher share count affects how much of the business each share represents.
That matters against the company's recent annual backdrop. Revenue was essentially flat in 2025 at $587.7 million, with a 3.5% operating margin. The latest six-month sales jump is substantial, but the margin has not expanded with it, and the cash engine has only just crossed zero.
The next quarterly report's operating cash flow will give the clearest comparison point, starting from $374,000 for the six months ended June 30.
Source: Babcock & Wilcox's Form 10-Q reported $374,000 of operating cash flow for the six months ended June 30, 2026.